MedHexim1
MedHexim1 focuses on Hexim1 as a biomarker and drug design target as strategy to develop a diagnostic test and therapy for prostate cancer. MedHexim1 Team: Eduardo Mascareno, PhD, President Manya Dhar-Mascareno, President
Read MoreHyperfine
Hyperfine – My company/technology is advanced analytics software for personalized medicine – the goal for my company is to assist in the creation of cures. Hyperfine Team: Bridget Osetinksy, CEO Bobby Mannepalli, COO
Read MoreZakan Theraputics
Zakan Therapeutics — A biological therapeutic that can directly attack metastatic cancer cells by delivering a payload of anti-cancer compounds while bypassing healthy cells. Zakan Theraputics Team: Arthee Jahangir Benjamin Caballero
Read MoreAision Biotechnologies
Prophylactic drugs that protect against depression and PTSD in a vaccine-like fashion. Rebecca Brachman, Co-Founder Christine Denny, PhD, Co-Founder
Read MoreSeeq
Seeq aims to advance precision medicine by creating a billion-person scale genomics dataset and making genome exploration approachable and inexpensive for consumers and researchers. Team: Kaja Wasik
Read MoreArdent
Ardent has developed technologies to transform “energy-storing” white adipose tissue (WAT) into “energy-burning” brown adipose tissue (BAT) for treatment of obesity, diabetes, and metabolic disease. Team: Luis Santos Brian Gillette
Read MoreVeripad
Veripad has created the most affordable and accessible system for checking the quality of medicines by using a paper chemical test card and companion mobile app. Team: Executive Leadership Bishoy Ghobryal, CEO Da Wi Shin, COO Y-Lan Nguyen, CAO Jason Ki, CTO
Read MoreChemitope Glycopeptide
Chemitope specializes in the chemical synthesis of complex glycopeptides for use in challenging vaccine applications, such as HIV. Team: Baptiste Aussedat, PhD William Walkowicz, PhD
Read MoreCalRegen, Inc.
CalRegen, Inc is a start-up biotechnology company formed on the discovery of calreticulin (CRT), as a novel biotherapeutic that has unique, diverse and broad ranging tissue regenerative qualities that will be developed for different indications including chronic wound healing, epidermal appendage (hair follicle) neogenesis, improving the cosmetic architecture of the skin, and healing of ophthalmic ulcers.…
Read MoreAlloMek
AlloMek is working on a small molecule based therapeutics for rare diseases. AlloMek Team: Uday Khire, Ph.D. MBA Co-Founder and CEO
Read More